Literature DB >> 20839901

X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice.

S Givvimani1, U Sen, N Tyagi, C Munjal, S C Tyagi.   

Abstract

Although protease activated receptor-1 (PAR-1) and matrix metalloproteinase-9 (MMP-9) play significant role in vascular remodelling in hyperhomocysteinemia (HHcy due to cystathionine beta synthase deficiency, CBS-/+) and diabetes, mechanism remains nebulous. We hypothesized that differential vascular density and remodelling in different vascular beds in HHcy and diabetes were responsible for an adaptive metabolic homeostasis during the pathogenesis. To test this hypothesis, vascular density in mice lacking PAR-1, MMP-9, CBS and Insulin-2 gene mutant (Ins2-/+, Akita) was measured and compared with wild type (WT, C57BL/6J) mice. The vascular density was detected by x-ray angiography using KODAK 4000 MM image station, using barium sulphate as contrasting agent. The % vascular density in the hearts of WT, CBS-/+ (HHcy), MMP-9-/-, PAR-1-/+ and Ins2-/+ (type-1 diabetes) was 100 ± 2.8, 85 ± 3.3, 90 ± 3.3, 95 ± 3.8 and 73 ± 1.7, respectively. The vascular density in CBS-/+ and Akita hearts decreased while it was increased in lungs of CBS-/+ and MMP-9-/-.There was decreased vascular density in liver and kidney of Akita mice. Vascular density in brain, kidney and mesentery was decreased in CBS-/+ mice. These findings support the notation that metabolic derangement in diabetes and HHcy causes the chronic decline and/or rarefaction in vascular density.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839901      PMCID: PMC3236441          DOI: 10.3109/13813455.2010.512042

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  28 in total

Review 1.  [Vascular risk factors and Alzheimer's disease].

Authors:  Pedro J Regalado Doña; Pilar Azpiazu Artigas; M Luisa Sánchez Guerra; Consuelo Almenar Monfort
Journal:  Rev Esp Geriatr Gerontol       Date:  2009-03-05

Review 2.  Plasma homocysteine and vascular disease in elderly patients with mental illness.

Authors:  Karin Nilsson; Lars Gustafson; Björn Hultberg
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

3.  Roles of matrix metalloproteinases in flow-induced outward vascular remodeling.

Authors:  Ryo Ota; Chie Kurihara; Tsung-Ling Tsou; William L Young; Yerem Yeghiazarians; Mayland Chang; Shahriar Mobashery; Atsuhiro Sakamoto; Tomoki Hashimoto
Journal:  J Cereb Blood Flow Metab       Date:  2009-06-10       Impact factor: 6.200

4.  Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat.

Authors:  Yan-hong Guo; Feng-ying Chen; Gui-song Wang; Li Chen; Wei Gao
Journal:  Chin Med J (Engl)       Date:  2008-11-20       Impact factor: 2.628

5.  Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study.

Authors:  M Kivipelto; S Annerbo; J Hultdin; L Bäckman; M Viitanen; L Fratiglioni; J Lökk
Journal:  Eur J Neurol       Date:  2009-04-21       Impact factor: 6.089

Review 6.  Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.

Authors:  Nikos E Tsopanoglou; Michael E Maragoudakis
Journal:  Semin Thromb Hemost       Date:  2007-10       Impact factor: 4.180

7.  The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats.

Authors:  Eleonora Distrutti; Andrea Mencarelli; Luca Santucci; Barbara Renga; Stefano Orlandi; Annibale Donini; Vijay Shah; Stefano Fiorucci
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

8.  Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment.

Authors:  Gaetano Gorgone; Francesca Ursini; Claudia Altamura; Federica Bressi; Mario Tombini; Giuseppe Curcio; Paola Chiovenda; Rosanna Squitti; Mauro Silvestrini; Riccardo Ientile; Francesco Pisani; Paolo Maria Rossini; Fabrizio Vernieri
Journal:  Atherosclerosis       Date:  2009-03-11       Impact factor: 5.162

9.  Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.

Authors:  Munish Kumar; Neetu Tyagi; Karni S Moshal; Utpal Sen; Soumi Kundu; Paras K Mishra; Srikanth Givvimani; Suresh C Tyagi
Journal:  Neurochem Int       Date:  2008-08-03       Impact factor: 3.921

10.  Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance.

Authors:  Isabel Sala; María Belén Sánchez-Saudinós; Laura Molina-Porcel; Estela Lázaro; Ignasi Gich; Jordi Clarimón; Francisco Blanco-Vaca; Rafael Blesa; Teresa Gómez-Isla; Alberto Lleó
Journal:  Dement Geriatr Cogn Disord       Date:  2008-11-20       Impact factor: 2.959

View more
  13 in total

1.  Hyperhomocysteinemia decreases intestinal motility leading to constipation.

Authors:  S Givvimani; C Munjal; N Narayanan; F Aqil; G Tyagi; N Metreveli; S C Tyagi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

Review 2.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

3.  Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid.

Authors:  Neetu Tyagi; Madhavi Kandel; Charu Munjal; Natia Qipshidze; Jonathan C Vacek; Sathnur B Pushpakumar; Naria Metreveli; Suresh C Tyagi
Journal:  J Orthop Res       Date:  2011-04-05       Impact factor: 3.494

4.  MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.

Authors:  Sourav Kundu; Sathnur Pushpakumar; Utpal Sen
Journal:  Nitric Oxide       Date:  2015-02-07       Impact factor: 4.427

5.  Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia.

Authors:  Sudhakar Veeranki; Srikanth Givvimani; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

6.  Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice.

Authors:  P K Kamat; A Kalani; S Givvimani; P B Sathnur; S C Tyagi; N Tyagi
Journal:  Neuroscience       Date:  2013-07-31       Impact factor: 3.590

7.  Sustained Inhibition of NF-κB Activity Mitigates Retinal Vasculopathy in Diabetes.

Authors:  Rubens P Homme; Harpal S Sandhu; Akash K George; Suresh C Tyagi; Mahavir Singh
Journal:  Am J Pathol       Date:  2021-02-26       Impact factor: 4.307

8.  Diabetic Stroke Severity: Epigenetic Remodeling and Neuronal, Glial, and Vascular Dysfunction.

Authors:  Anuradha Kalani; Pradip Kumar Kamat; Neetu Tyagi
Journal:  Diabetes       Date:  2015-10-15       Impact factor: 9.461

Review 9.  In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast.

Authors:  Connor A Wathen; Nathan Foje; Tony van Avermaete; Bernadette Miramontes; Sarah E Chapaman; Todd A Sasser; Raghuraman Kannan; Steven Gerstler; W Matthew Leevy
Journal:  Sensors (Basel)       Date:  2013-05-27       Impact factor: 3.576

10.  Exercise Mitigates Alcohol Induced Endoplasmic Reticulum Stress Mediated Cognitive Impairment through ATF6-Herp Signaling.

Authors:  Akash K George; Jyotirmaya Behera; Kimberly E Kelly; Nandan K Mondal; Kennedy P Richardson; Neetu Tyagi
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.